Q3 2026
Fund IDraft1 review flag
Opening
# Hemrock Ventures — Fund I
Q3 2026 Portfolio Update
Dear Limited Partners,
This draft covers Fund I for the quarter ended September 30, 2026. NovaTech, AdVantage and RouteWise reported; GreenLeaf Bio has not yet sent its Q3 update.
---
### NovaTech
NovaTech's MRR reached $371K in September, up 12% on June, with net revenue retention of 124%. Burn held at $101K a month and cash was $3.8M at quarter end. A new VP Sales starts in November. Two larger deals slipped to January.
---
### AdVantage
AdVantage closed September at $421K MRR, up 8% on June, with 2.5% logo churn. Programmatic TV has nine paying retailers. The DSP partnership flagged last quarter did not close.
---
### RouteWise
RouteWise reached $7.2M ARR at September 30 with 88 customers and 70% gross margin; Europe is 9% of new ARR. The company expects to close a Series C at a higher valuation in Q4 and has asked for the fund's follow-on decision by the end of October.
---
### GreenLeaf Bio
GreenLeaf Bio has not sent its Q3 update. The last report (Q2) put cash at $950K with about five months of runway and a bridge round in progress.
NovaTech
NovaTech's MRR reached $371K in September, up 12% on June, with net revenue retention of 124%. Burn held at $101K a month and cash was $3.8M at quarter end. A new VP Sales starts in November. Two larger deals slipped to January.
AdVantage
AdVantage closed September at $421K MRR, up 8% on June, with 2.5% logo churn. Programmatic TV has nine paying retailers. The DSP partnership flagged last quarter did not close.
RouteWise
RouteWise reached $7.2M ARR at September 30 with 88 customers and 70% gross margin; Europe is 9% of new ARR. The company expects to close a Series C at a higher valuation in Q4 and has asked for the fund's follow-on decision by the end of October.
GreenLeaf Bio
GreenLeaf Bio has not sent its Q3 update. The last report (Q2) put cash at $950K with about five months of runway and a bridge round in progress.